drugset / Trial / NCT04675177

Polidocanol Foam VS Artery Ligation in Hemorrhoidal Disease

NCT04675177

Phase 2/3 Completed 45 enrolled University of Porto
RandomizedParallel-groupOpen-labelTreatment

Summary

Background: Hemorrhoidal disease is extremely frequent in the adult population and, as a benign pathology, the treatment should be guided by the patient's symptoms. Treatment of hemorrhoidal disease includes a conservative approach, office-based treatments and surgery. This study is aimed to evaluate and compare the efficacy and safety of the treatment of hemorrhoidal disease with non-surgical office-based method polidocanol foam sclerotherapy (SP) and the surgical technique doppler-guided hemorrhoidal artery ligation with recto-anal repair. Methods: Prospective, unicentric study including patients with symptomatic hemorrhoidal disease grade II and III refractory to conservative therapy, submitted either to SP (n=24) or to HAL-RAR procedure (n=21), during a recruitment period of 6 months. Patients were evaluated for efficacy (Sodergren's scale of symptoms and severity of bleeding) and safety (complications and implication in personal and professional life), up to one month after treatment. In follow-up period (6 months) participants were evaluated for hemorrhoidal disease recurrence.

Timeline

Start
2019-09-01
Primary completion
2020-02-01
Completion
2020-03-25

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polidocanol Other / unclassified 4 ml

Indications